A survey to explore the current use of injection therapy as part of a conservative treatment plan for degenerative meniscal lesions within UK based, injection trained physiotherapy members of the society of musculoskeletal medicine

Article


Arithoppah, R., Caldwell, K. and Smith, G. 2016. A survey to explore the current use of injection therapy as part of a conservative treatment plan for degenerative meniscal lesions within UK based, injection trained physiotherapy members of the society of musculoskeletal medicine. International Musculoskeletal Medicine. 38 (2), pp. 63-73. https://doi.org/10.1080/17536146.2016.1237063
TypeArticle
TitleA survey to explore the current use of injection therapy as part of a conservative treatment plan for degenerative meniscal lesions within UK based, injection trained physiotherapy members of the society of musculoskeletal medicine
AuthorsArithoppah, R., Caldwell, K. and Smith, G.
Abstract

Objectives: To explore the current use of injection therapy as part of a conservative treatment plan for degenerative meniscal lesions (DML) within UK based physiotherapy members of the Society of Musculoskeletal Medicine (SOMM) with injection training.
Methods: An online survey was distributed via email to all UK based, SOMM physiotherapists who had trained and received their injection diploma through the SOMM (n = 203) with a response rate of 32% (n = 64). The data were analysed using descriptive statistics, contingency tables and the Fisher's exact test. A P value ≤0.05 was considered significant. Ethical clearance was gained through the SOMM and Middlesex University.
Results: Of the respondents 98% (n = 62) of current UK based, injection trained SOMM physiotherapists utilize conservative treatment for DML of which 81% (n = 52) include injection therapy. Seventy-seven per cent (n = 49) who currently use injection therapy for DML administer a combination of 40 mg Depomedrone combined with local anaesthetic via a patellofemoral approach. Those not using injection therapy as part of their management of DML attributed this to local department restrictions and lack of evidence.
Discussion: This research has helped further understand the use of injection therapy for DML and where it fits within a conservative treatment plan. The benefit from injection therapy reported by respondents is similar to previous research but could be influenced by injection exposure and potentially steroid choice. Overall a consensus is starting to appear regarding dosage, steroid, and administration; however, differences arise when comparing individual department guidelines to CSP and NICE guidelines.

PublisherTaylor and Francis
JournalInternational Musculoskeletal Medicine
ISSN1753-6146
Publication dates
Online29 Sep 2016
Print02 Apr 2016
Publication process dates
Deposited30 Sep 2016
Accepted22 Sep 2016
Output statusPublished
Accepted author manuscript
Accepted author manuscript
Copyright Statement

This is an Accepted Manuscript of an article published by Taylor & Francis in International Musculoskeletal Medicine on 29/09/2016], available online: http://www.tandfonline.com/10.1080/17536146.2016.1237063

Digital Object Identifier (DOI)https://doi.org/10.1080/17536146.2016.1237063
LanguageEnglish
Permalink -

https://repository.mdx.ac.uk/item/86q40

Download files


Accepted author manuscript
  • 13
    total views
  • 30
    total downloads
  • 1
    views this month
  • 2
    downloads this month

Export as